Home » Authors » Anette Breindl

Articles by Anette Breindl

Studies Shine Light, Literally, On Neural Substrates Of Sleep

Oct. 18, 2007

By Anette Breindl

Second Suspect Chemokine Receptor Identified For Cancer

Oct. 17, 2007

By Anette Breindl

Nobel Laureate's Interests Are As Broad As His Technology

Oct. 17, 2007

By Anette Breindl

Second Suspect Chemokine Receptor Identified For Cancer

Oct. 17, 2007

By Anette Breindl

Nobel Laureate's Interests Are As Broad As His Technology

Oct. 17, 2007

By Anette Breindl

Nobel Laureate's Interests Are As Broad As His Technology

Oct. 15, 2007

By Anette Breindl

Nobel Laureate's Interests Are As Broad As His Technology

Oct. 15, 2007

By Anette Breindl

Applications Are Everywhere For This Year's Science Prizes

Oct. 11, 2007

By Anette Breindl

Applications Are Everywhere For This Year's Science Prizes

Oct. 11, 2007

By Anette Breindl

Targeting Cellular MicroRNA Can Flush HIV Out Of Hiding

Oct. 8, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...